Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
Abstract Cancer therapeutic vaccine can induce antigen-specific immune response, which has shown great potential in cancer immunotherapy. As the key factor of vaccine, antigen plays a central role in eliciting antitumor immunity. However, the insufficient antigen delivery and low efficiency of antig...
Main Authors: | Chen Shi, Chen Jian, Lulu Wang, Chen Gao, Ting Yang, Zhiwen Fu, Tingting Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-023-02106-8 |
Similar Items
-
Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
by: Hu Chen, et al.
Published: (2022-06-01) -
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
by: Shanshan Cheng, et al.
Published: (2020-04-01) -
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
by: Heng Dong, et al.
Published: (2023-06-01) -
Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
by: Xingliang Fang, et al.
Published: (2022-08-01) -
Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
by: Chen Shi, et al.
Published: (2023-11-01)